US Stock MarketDetailed Quotes
OMGA Omega Therapeutics
- 0.883
- +0.087+10.96%
Close Nov 29 13:00 ET
- 0.890
- +0.007+0.79%
Post 15:31 ET
48.89MMarket Cap-668P/E (TTM)
0.889High0.810Low188.52KVolume0.836Open0.796Pre Close160.45KTurnover0.88%Turnover RatioLossP/E (Static)55.37MShares6.30052wk High4.25P/B19.02MFloat Cap0.75052wk Low--Dividend TTM21.54MShs Float31.410Historical High--Div YieldTTM9.95%Amplitude0.750Historical Low0.851Avg Price1Lot Size
Omega Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 214.32%2.61M | 181.16%2.13M | 357.36%2.36M | 49.25%3.09M | 34.56%989K | 39.66%831K | 59.45%759K | 92.54%516K | 1,339.58%2.07M | 410.42%735K |
| Operating revenue | 214.32%2.61M | 181.16%2.13M | 357.36%2.36M | 49.25%3.09M | 34.56%989K | 39.66%831K | 59.45%759K | 92.54%516K | 1,339.58%2.07M | 410.42%735K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -19.81%19.03M | -40.78%18.71M | -13.38%22.81M | -1.42%103.36M | -31.59%21.69M | -10.71%23.73M | 20.01%31.6M | 30.19%26.33M | 58.42%104.84M | 52.35%31.7M |
| Selling and administrative expenses | -13.88%6.23M | -11.94%5.77M | 18.47%7.4M | 10.62%26.19M | -14.56%6.16M | 39.05%7.23M | 5.72%6.56M | 15.48%6.24M | 42.58%23.67M | 26.60%7.21M |
| -General and administrative expense | -13.88%6.23M | -11.94%5.77M | 18.47%7.4M | 10.62%26.19M | -14.56%6.16M | 39.05%7.23M | 5.72%6.56M | 15.48%6.24M | 42.58%23.67M | 26.60%7.21M |
| Research and development costs | -22.41%12.81M | -48.33%12.94M | -23.27%15.42M | -4.93%77.17M | -42.13%15.53M | -20.15%16.51M | 29.17%25.04M | 41.58%20.09M | 69.57%81.17M | 83.28%26.84M |
| Operating profit | 28.31%-16.42M | 46.24%-16.58M | 20.79%-20.45M | 2.44%-100.26M | 33.16%-20.7M | 11.86%-22.9M | -19.29%-30.84M | -29.36%-25.82M | -55.63%-102.77M | -49.86%-30.97M |
| Net non-operating interest income expense | -97.95%14K | -68.76%299K | -51.47%331K | 1,165.77%2.81M | 96.37%487K | 271.74%684K | 1,840.00%957K | 540.00%682K | 124.40%222K | 246.75%248K |
| Non-operating interest income | ---- | -68.76%299K | -51.47%331K | 1,165.77%2.81M | ---- | ---- | --957K | --682K | --222K | ---- |
| Total other finance cost | 97.95%-14K | ---- | ---- | ---- | ---- | -271.74%-684K | ---- | ---- | ---- | ---- |
| Other net income (expense) | -31.03%-38K | -112.24%-24K | 93.71%-9K | 114.65%23K | 98.13%-2K | -1,550.00%-29K | 6,633.33%196K | -186.00%-143K | 88.27%-157K | -409.52%-107K |
| Other non- operating income (expenses) | -31.03%-38K | -112.24%-24K | 93.71%-9K | 114.65%23K | 98.13%-2K | -1,550.00%-29K | 6,633.33%196K | -186.00%-143K | -460.71%-157K | -409.52%-107K |
| Income before tax | 26.09%-16.44M | 45.08%-16.31M | 20.37%-20.13M | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M |
| Income tax | ||||||||||
| Net income | 26.09%-16.44M | 45.08%-16.31M | 20.37%-20.13M | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M |
| Net income continuous Operations | 26.09%-16.44M | 45.08%-16.31M | 20.37%-20.13M | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 26.09%-16.44M | 45.08%-16.31M | 20.37%-20.13M | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 26.09%-16.44M | 45.08%-16.31M | 20.37%-20.13M | 5.13%-97.43M | 34.43%-20.21M | 13.76%-22.25M | -14.57%-29.69M | -25.37%-25.28M | -50.41%-102.7M | -47.82%-30.83M |
| Basic earnings per share | 25.00%-0.3 | 44.44%-0.3 | 28.00%-0.36 | 15.89%-1.8 | 43.75%-0.36 | 25.93%-0.4 | 0.00%-0.54 | -19.05%-0.5 | 29.84%-2.14 | -45.45%-0.64 |
| Diluted earnings per share | 25.00%-0.3 | 44.44%-0.3 | 28.00%-0.36 | 15.89%-1.8 | 43.75%-0.36 | 25.93%-0.4 | 0.00%-0.54 | -19.05%-0.5 | 29.84%-2.14 | -45.45%-0.64 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
